AMINO-ACID AND DIPEPTIDE DERIVATIVES OF DAUNORUBICIN .2. CELLULAR PHARMACOLOGY AND ANTI-TUMOR ACTIVITY ON L1210 LEUKEMIC-CELLS INVITRO AND INVIVO
AMINO-ACID AND DIPEPTIDE DERIVATIVES OF DAUNORUBICIN .2. CELLULAR PHARMACOLOGY AND ANTI-TUMOR ACTIVITY ON L1210 LEUKEMIC-CELLS INVITRO AND INVIVO
复制标题
多柔比星的氨基酸和二肽衍生物 .2. 细胞药理学及对 L1210 白血病细胞的体外和体内抗肿瘤活性
DOI:
10.1021/jm00185a004
复制
发表时间:
1980-01-01
影响因子:
7.3
通讯作者:
TROUET, A
中科院分区:
文献类型:
--
作者:
BAURAIN, R;MASQUELIER, M;TROUET, A
The accumulation of amino acid and dipeptide derivatives of DNR (daunorubicin) was studied in vitro on mouse leukemia L1210 cells. Only Leu-DNR reached accumulation levels close to DNR, while Val-DNR, Ile-DNR and Leu-Leu-DNR reach intermediate values. Intracellular DNR was found when the L210 cells were incubated in the presence of DNR, Leu-Leu-DNR, Leu-Ala-DNR and Leu-DNR. The cytostatic activity of the derivatives in vitro on L1210 cells cannot be correlated with their uptake or conversion into DNR. At equitoxic doses given i.v. on the i.v. inoculated form of L1210 leukemia, all the derivatives are less active than DNR. When given i.v. on the s.c. inoculated L120 leukemia, Leu-DNR, Ala-Leu-DNR and Leu-Leu-DNR are much more active than DNR with a striking increase in ILS and reduction of tumor progression. The superiority of those compounds could be due to their greater hydrophobicity and to their hydrolysis in situ by enzymes secreted by tumor cells or present on the tumor cells surface.